Longitudinal assessment of cerebral perfusion and vascular response to hypoventilation in a bigenic mouse model of Alzheimer's disease with amyloid and tau pathology
暂无分享,去创建一个
T. Dresselaers | U. Himmelreich | F. van Leuven | T. Struys | A. Kremer | P. Borghgraef | Kristof Govaerts | B. Lechat
[1] Axel Montagne,et al. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease , 2017, Nature Reviews Neuroscience.
[2] T. Dresselaers,et al. In vivo evidence for long-term vascular remodeling resulting from chronic cerebral hypoperfusion in mice , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] Arthur W. Toga,et al. Brain imaging of neurovascular dysfunction in Alzheimer’s disease , 2016, Acta Neuropathologica.
[4] Marc Modat,et al. Imaging the accumulation and suppression of tau pathology using multiparametric MRI , 2016, Neurobiology of Aging.
[5] Sébastien Ourselin,et al. In vivo imaging of tau pathology using multi-parametric quantitative MRI , 2015, NeuroImage.
[6] Holly E. Holmes,et al. Increased Cerebral Vascular Reactivity in the Tau Expressing rTg4510 Mouse: Evidence against the Role of Tau Pathology to Impair Vascular Health in Alzheimer's Disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] A. Fagan,et al. Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective. , 2015, Advances in medical sciences.
[8] H. Devijver,et al. Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β , 2014, The European journal of neuroscience.
[9] D. Bates,et al. Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.
[10] F. Calon,et al. Altered cerebral vascular volumes and solute transport at the blood–brain barriers of two transgenic mouse models of Alzheimer's disease , 2014, Neuropharmacology.
[11] R. Welsh,et al. 25 years of neuroimaging in amyotrophic lateral sclerosis , 2013, Nature Reviews Neurology.
[12] Bojana Stefanovic,et al. Hemodynamic effects of cholinesterase inhibition in mild Alzheimer's disease , 2013, Journal of magnetic resonance imaging : JMRI.
[13] François Hébert,et al. Cortical atrophy and hypoperfusion in a transgenic mouse model of Alzheimer's disease , 2013, Neurobiology of Aging.
[14] Henry Rusinek,et al. Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[15] Bojana Stefanovic,et al. Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease. , 2012, Brain : a journal of neurology.
[16] Willy Gsell,et al. Anaesthesia and physiological monitoring during in vivo imaging of laboratory rodents: considerations on experimental outcomes and animal welfare , 2012, EJNMMI Research.
[17] H. Devijver,et al. Isoflurane anesthesia precipitates tauopathy and upper airways dysfunction in pre-symptomatic Tau.P301L mice: Possible implication for neurodegenerative diseases , 2012, Neurobiology of Disease.
[18] Jinsoo Uh,et al. Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease , 2012, Neurobiology of Aging.
[19] F. van Leuven,et al. Early Improved and Late Defective Cognition Is Reflected by Dendritic Spines in Tau.P301L Mice , 2011, The Journal of Neuroscience.
[20] Wolfgang Eberle,et al. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: A multi-electrode array study , 2011, Neurobiology of Disease.
[21] W. Robberecht,et al. Response of mouse brain perfusion to hypo‐ and hyperventilation measured by arterial spin labeling , 2011, Magnetic resonance in medicine.
[22] F. LaFerla,et al. Long term changes in phospho-APP and tau aggregation in the 3xTg-AD mice following cerebral ischemia , 2011, Neuroscience Letters.
[23] Anne Corbett,et al. Alzheimer's disease , 2011, The Lancet.
[24] Richard Watts,et al. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. , 2011, Brain : a journal of neurology.
[25] Markus Rudin,et al. Vascular response to acetazolamide decreases as a function of age in the arcAβ mouse model of cerebral amyloidosis , 2010, Neurobiology of Disease.
[26] J. Detre,et al. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[27] Marc Dhenain,et al. Detection of vascular alterations by in vivo magnetic resonance angiography and histology in APP/PS1 mouse model of Alzheimer’s disease , 2010, Magnetic Resonance Materials in Physics, Biology and Medicine.
[28] B. Carnes,et al. Basal and hypercapnia-altered cerebrovascular perfusion predict mild cognitive impairment in aging rodents , 2009, Neuroscience.
[29] F. LaFerla,et al. Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease , 2009, Neuropharmacology.
[30] M. Schmidt,et al. Non-invasive characterization of β-amyloid1-40 vasoactivity by functional magnetic resonance imaging in mice , 2008, Neuroscience.
[31] F. van Leuven,et al. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. , 2008, The American journal of pathology.
[32] Phillip B. Jones,et al. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. , 2007, Brain : a journal of neurology.
[33] Gian Luigi Lenzi,et al. Cerebrovascular Reactivity in Degenerative and Vascular Dementia: A Transcranial Doppler Study , 2007, European Neurology.
[34] Fabrizio Vernieri,et al. Cerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease , 2006, Stroke.
[35] Berislav V. Zlokovic,et al. Neurovascular mechanisms of Alzheimer's neurodegeneration , 2005, Trends in Neurosciences.
[36] F. van Leuven,et al. Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice* , 2005, Journal of Biological Chemistry.
[37] Y. Tagaito,et al. Phenotypic variation in cardiovascular responses to acute hypoxic and hypercapnic exposure in mice. , 2004, Physiological genomics.
[38] Markus Rudin,et al. Compromised Hemodynamic Response in Amyloid Precursor Protein Transgenic Mice , 2002, The Journal of Neuroscience.
[39] Donald S. Williams,et al. Cerebral perfusion during anesthesia with fentanyl, isoflurane, or pentobarbital in normal rats studied by arterial spin‐labeled MRI , 2001, Magnetic resonance in medicine.
[40] George A. Carlson,et al. Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[41] Veerle Baekelandt,et al. Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.
[42] Seong-Gi Kim. Quantification of relative cerebral blood flow change by flow‐sensitive alternating inversion recovery (FAIR) technique: Application to functional mapping , 1995, Magnetic resonance in medicine.